Lisa M Butler

46PUBLICATIONS
261CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jun 02, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

|Apr 03, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli

|Mar 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Sara Bleve, Francesco Ravera, Silvia Rodrigues

|Mar 03, 2026
Connecting the Cell Cycle to Lipid Metabolism in Cancer: Their Reciprocal Roles and Opportunity for Therapeutic Exploitation.

Joshua T Hodgson, Lisa M Butler, Margaret M Centenera

|Dec 03, 2025
Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets.

Jasmine T Plummer, Felipe Segato Dezem, David P Cook

|Nov 27, 2025
Personalized intensification of treatment for hormone-sensitive prostate cancer.

Michael A Cilento, Lisa M Butler, Louise Emmett

Pageof 8

Frequent Collaborators

10 joint publications

Luke A Selth

10 joint publications

Johannes V Swinnen

9 joint publications

Andrew J Hoy

8 joint publications

Zeyad D Nassar